Table 1.
Serum biochemical and hormonal outcomes.
| Outcomes | Groups | |||
|---|---|---|---|---|
| C | C + Y | DM | DM + Y | |
| Initial glycemia (mg/dL) | 128 ± 14.75 | 119.6 ± 14.76 | 416.11 ± 15.55∗ | 395.33 ± 19.05# |
| Final glycemia (mg/dL) | 94 ± 17.90 | 88.66 ± 18.87 | 299.75 ± 20.02∗ | 109.71 ± 19.46† |
| Insulin (pmol/L) | 32.25 ± 2.45 | 30.87 ± 2.60 | 20.24 ± 3.30∗ | 30.22 ± 3.01† |
| TG (mg/dL) | 54.74 ± 3.26 | 71.53 ± 3.64∗ | 89.77 ± 3.89∗ | 64.42 ± 4.21† |
| NEFA (mEq/L) | 0.34 ± 0.03 | 0.38 ± 0.03 | 0.43 ± 0.03 | 0.30 ± 0.03† |
The data are represented as the mean ± SEM. Statistical analysis was performed using the generalized linear model and two-way analysis of variance test complemented with a nonparametric test. Significant values are represented by P < 0.05. ∗Versus C; #versus C + Y; †versus DM; C: controls; C + Y: controls treated with Yacon leaf extract; DM: diabetic controls; DM + Y: diabetic rats treated with Yacon; TG: triacylglycerol; NEFA: nonesterified fatty acid.